Abstract

A REVIEW ON NEUROMEDICINE

Vishruti Patel*, Pooja Patel and Dr. Umesh Upadhyay

.

Abstract

Phytocannabionids (andsynthetic analogs thereof) are gaining significant attention as promising leads in modern medicine. The frequency, complexity and morbidity of neurodegenerative disease make them a great challenge for now a day’s medicine. The treatments currently used for Parkinson’s disease the second most prevalent are only symptomatic. Mitochondrial oxidative damage and dysfunction contribute to a wide range of human disease. Proteasome malfunction parallels abnormal amyloid accumulation in Alzheimer's disease (AD). The development of proteasome activators for AD treatment. They large protein involved in the pathogenesis of Parkinson's disease (PD). Among Neurodegenerative disorders, Alzheimer's disease (AD) is the most common type of dementia, and there is an urgent need to discover new and efficacious forms of treatment for it. They such targets by allosteric modulators in an advantageous manner, as this may decrease the likelihood of side effects. The purpose of this review is to present an overview of compounds that act as allosteric modulators of the main biological targets related to AD.

Keywords: Alzheimers disease, Parkinsons disease, Stem cells and stroke.